New skin serum passes safety check in small trial
NCT ID NCT07517900
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed study tested whether a topical serum containing Mitopure is safe for healthy adults. Forty participants applied the serum repeatedly over two weeks. Researchers checked for skin irritation and asked about product traits. The trial focused only on safety, not on whether the serum improves skin appearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Mitopure topical serum
What this could lead to
If successful, this could support the development of a safe skin serum for cosmetic use.
What could go wrong
This is a small, early safety study in healthy people, not designed to test effectiveness. Results may not apply to people with skin conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PCR Corp
Manchester, M13 0AF, United Kingdom